e-learning
resources
Milan 2017
Wednesday, 13.09.2017
Asthma: mechanisms and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Living with severe asthma year 2016
P. Katsaounou (Athens, Greece)
Source:
International Congress 2017 – Asthma: mechanisms and treatment
Session:
Asthma: mechanisms and treatment
Session type:
Poster Discussion
Number:
4682
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Katsaounou (Athens, Greece). Living with severe asthma year 2016. 4682
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Living well with severe asthma
Source: Breathe, 15 (2) e40; 10.1183/20734735.0165-2019
Year: 2019
Management of severe asthma in adults in 2020
Source: International Congress 2019 – New recommendations and priorities for asthma management
Year: 2019
The year in asthma
Source: International Congress 2018 – Clinical Year in Review
Year: 2018
Characteristics of severe asthma in China with one year follow-up: the C-BIOPRED study
Source: International Congress 2019 – Asthma and allergies worldwide
Year: 2019
Proportion of complete responders after one year of treatment with biologics for severe asthma - Results from the nationwide Danish Severe Asthma Register.
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Asthma hospitalization rates and asthma mortality in Chilean Children: 2008-2014
Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations
Year: 2018
Omalizumab in severe uncontrolled asthma: two and a half year clinical experience
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
One year following a real life experience of omalizumab for moderate to severe persistent allergic asthma in Malta
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013
Quality of life in adolescents with asthma. A five year follow up
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007
Live from Amsterdam: Co-morbidities in severe asthma across the life course
Source: ERS Satellite 2018
Year: 2018
Age at asthma onset and lung function among 19 year old asthmatics
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016
Asthma, asthma-like symptoms and disability in the Quid R elderly cohort
Source: Eur Respir J 2004; 24: Suppl. 48, 144s
Year: 2004
Risk of exacerbations in COPD and asthma patients living in the neighbourhood of livestock farms
Source: International Congress 2015 – Novel occupational exposures and responses
Year: 2015
Predictors of 90 day readmission in hospitalized patients for asthma exacerbation
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Management of severe asthma in children
Source: International Congress 2018 – ME11 Management of severe asthma in children FULLY BOOKED
Year: 2018
Management of severe asthma in children
Source: Virtual Congress 2020 – Reducing the burden of asthma
Year: 2020
Management of severe asthma in children
Source: Annual Congress 2010 - ERS/[italic]Lancet[/italic] Asthma
Year: 2010
Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey
Source: Eur Respir J 2013; 42: 1224-1233
Year: 2013
ME11 Management of severe asthma in children
Source: Paris 2018 - Educational material
Year: 2018
COPD exacerbation phenotypes in a five year hospitalisation cohort
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept